Funding for this research was provided by:
First Online: 19 April 2019
: DVA has no competing interests to declare. SVB is co-inventor of a patent relating to circulating tumor DNA detection technology, which has been licensed to Roche Molecular Diagnostics.LLS is a consultant for Merck, Pfizer, Celgene, AstraZeneca/Medimmune, Morphosys, Roche, GeneSeeq, Loxo, Oncorus, Symphogen and Mirati. Her spouse holds Agios stock.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.